420 Stevens Avenue
Suite 230
Solana Beach, CA 92075
United States
858 345 1494
https://www.evokepharma.com
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 4
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Matthew J. D'Onofrio MBA | Co-Founder, CEO & Director | 779,37k | N/A | 1970 |
Dr. Marilyn R. Carlson D.M.D., M.D., RAC. | Chief Medical Officer | 681,24k | N/A | 1948 |
Mr. Mark A. Kowieski CPA | Chief Financial Officer | N/A | N/A | 1977 |
Mr. Christopher Quesenberry | Chief Commercial Officer - Gimoti (TM) | N/A | N/A | N/A |
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Evoke Pharma, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.